Ampicillin
- Generic Name
- Ampicillin
- Brand Names
- Unasyn
- Drug Type
- Small Molecule
- Chemical Formula
- C16H19N3O4S
- CAS Number
- 69-53-4
- Unique Ingredient Identifier
- 7C782967RD
- Background
Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic.
- Indication
For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc
- Associated Conditions
- Bacterial Infections, Endocarditis, Gastrointestinal Tract Infections, Genitourinary tract infection, Infection, Infection caused by eikenella corrodens, Listeria infection, Meningitis, Bacterial, Pertussis, Respiratory Tract Infections (RTI), Salmonella, Septicemia, Shigella, Subcutaneous bacterial infection, Urinary Tract Infection, Bacterial skin infections, Disease caused by Salmonella typhi, Perinatal group B streptococcus, Susceptible Bacterial Infections
- Associated Therapies
- -
Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Uji Takeda Hospital
- Target Recruit Count
- 70
- Registration Number
- NCT06368102
- Locations
- 🇯🇵
Uji Takeda Hospital, Uji, Japan
NICU Antibiotics and Outcomes (NANO) Follow-up Study
- Conditions
- Interventions
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- Sharp HealthCare
- Target Recruit Count
- 802
- Registration Number
- NCT05977400
- Locations
- 🇺🇸
Westchester Medical Center, Valhalla, New York, United States
🇺🇸Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States
🇨🇦Sinai Health System, Toronto, Canada
Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition
- Conditions
- Interventions
- First Posted Date
- 2021-09-21
- Last Posted Date
- 2021-09-30
- Lead Sponsor
- Makerere University
- Target Recruit Count
- 300
- Registration Number
- NCT05051163
- Locations
- 🇺🇬
Makerere University College of Health Sciences, Kampala, Central, Uganda
Azithromycin for Preterm Pre-labor Rupture of Membranes
- Conditions
- Interventions
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2024-04-24
- Lead Sponsor
- Assiut University
- Target Recruit Count
- 300
- Registration Number
- NCT04202380
- Locations
- 🇪🇬
Women Health Hospital - Assiut university, Assiut, Egypt
A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia
- First Posted Date
- 2019-08-01
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 4392
- Registration Number
- NCT04041791
- Locations
- 🇰🇪
Machakos Level 5 Hospital, Machakos, Kenya
NICU Antibiotics and Outcomes Trial
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2024-01-17
- Lead Sponsor
- Michael Morowitz
- Target Recruit Count
- 802
- Registration Number
- NCT03997266
- Locations
- 🇺🇸
Pennsylvania Hospital/The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Alfred I. duPont for Children of the Nemours Foundation, Philadelphia, Pennsylvania, United States
🇺🇸Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
Treatment of ppROM With Erythromycin vs. Azithromycin Trial
- Conditions
- Interventions
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2024-06-25
- Target Recruit Count
- 21
- Registration Number
- NCT03060473
- Locations
- 🇺🇸
St. David's North Austin Medical Center, Austin, Texas, United States
🇺🇸University of Texas Medical Branch, Galveston, Texas, United States
🇺🇸University of Utah, Salt Lake City, Utah, United States
A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome
- Conditions
- Interventions
- First Posted Date
- 2015-06-22
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- University of Chicago
- Target Recruit Count
- 27
- Registration Number
- NCT02477423
- Locations
- 🇺🇸
University of Chicago Medical Center - Comer Children's Hospital, Chicago, Illinois, United States
Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling of Ampicillin and Gentamicin in Peripartum Patients
- Conditions
- Interventions
- First Posted Date
- 2015-04-28
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Stanford University
- Target Recruit Count
- 45
- Registration Number
- NCT02427932
- Locations
- 🇺🇸
Lucille Packard Children's Hospital, Palo Alto, California, United States
Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis
- Conditions
- Interventions
- First Posted Date
- 2015-04-23
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 11
- Registration Number
- NCT02424734
- Locations
- 🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States
🇭🇺Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, Gyermek-, Koraszulott es Csecsemoosztaly, Budapest, Hungary
🇭🇺Egyesitett Szent Istvan es Szent Laszlo Korhaz - Rendelointezet, Gyermekinfektologiai Osztaly, Budapest, Hungary
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.